Wyeth Sonata To Be Promoted By 600 Elan Reps Through Deal For U.S. Rights
Executive Summary
Elan's 600-rep primary care and neurology sales forces will market Wyeth-Ayerst's insomnia treatment Sonata in the U.S. under a strategic alliance announced Dec. 20